leisure time -WSS

leisure time

author：Wikipedia 2025-08-10 11:42:45 - browse：7

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： FDA's Woodcock to retire early next year

Wikipedia

WSS

Astellas still sees hope in its gene therapy after four deaths

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Childhood cancer progress stalls for Black, Hispanic kids: Report

David Sabatini, ex

Morphosys mixed study results for blood cancer drug

Astellas still sees hope in its gene therapy after four deaths

focus

leisure time

hotspot

Virginia high school admissions case could be legal follow

Hospitals look to new technology to keep health care workers safe

Psychedelics group wrestles with new pharma identity

Hospitals look to new technology to keep health care workers safe

Peter Hotez and the public health issue of online harassment

Astellas still sees hope in its gene therapy after four deaths

Walensky prepares to leave CDC — and Congress — behind

David Sabatini, ex

Moonlake's readout produced a cash windfall. Risks remain

Poor hospice wound care hurts patients and families

knowledge

Why medical students are struggling with mental health

Congress must reauthorize a committee to support older Americans

In key trial, Verve's treatment lowers cholesterol levels in patients

David Sabatini, ex

NYU radiologists take on the challenge of expensive MRI machines

In key trial, Verve's treatment lowers cholesterol levels in patients

leisure time

focus

Wikipedia

explore